PAR-25-096 - Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Research on rare cancers across the cancer control continuum NOT-CA-25-010 NCI Dec 30, 2024 Sep 9, 2025 R01, R03, R21, U34, R34, P01
Notice of Special Interest (NOSI): Survivorship Research for People Living with Advanced and Metastatic Cancers NOT-CA-25-024 NCI Dec 17, 2024 Sep 9, 2025 U34, R34, R01, R03, R21, P01
For technical issues E-mail OER Webmaster